The "Tas2r" designation typically refers to the family of Type 2 taste receptors (T2Rs), which are G protein-coupled receptors (GPCRs) involved in the detection of bitter compounds.The T2R family in humans is encoded by a cluster of genes located on various chromosomes, and each gene is denoted by a unique number, such as TAS2R1, TAS2R10, and so forth. These receptors are expressed in the taste receptor cells of the tongue and are responsible for the perception of bitterness, a taste modality that can trigger aversion and is thought to have evolved as a protective mechanism against the ingestion of toxic substances.
T2R proteins are characterized by their seven transmembrane domains, a hallmark of GPCRs, which allow them to span the cell membrane and transmit extracellular ligand-binding events into intracellular responses. Upon binding to bitter compounds, T2Rs activate a G protein, specifically gustducin, which in turn leads to the activation of downstream signaling pathways. This results in an increase in intracellular calcium levels and neurotransmitter release, ultimately conveying the taste signal to the brain for perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-adrenergic receptor antagonist, potentially influencing GPCR signaling pathways, including T2R04. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Acts as a GPCR antagonist, potentially affecting various GPCRs including T2R04. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $199.00 $460.00 $1479.00 | 1 | |
Gs alpha subunit inhibitor, potentially affecting GPCR-mediated signaling pathways like T2R04. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Adenylyl cyclase inhibitor, potentially impacting cAMP pathways and thereby influencing T2R04 activity. | ||||||
KI 8751 | 228559-41-9 | sc-203090 | 5 mg | $139.00 | 2 | |
Gq inhibitor, potentially affecting GPCR signaling pathways including T2R04. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Protein kinase C inhibitor, potentially influencing pathways related to GPCR signaling, including T2R04. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inhibits Gi/o alpha subunits of G proteins, potentially modulating GPCR-mediated signaling pathways of T2R04. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
Protein kinase A inhibitor, potentially affecting cAMP-dependent pathways and indirectly influencing T2R04. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, disrupting PI3K/Akt signaling pathway, potentially affecting pathways interacting with T2R04 function. | ||||||